NCT02001025
Unknown
Not Applicable
Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study
Rudolf Berger1 site in 1 country60 target enrollmentNovember 2013
ConditionsBioresorbable Scaffolds
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bioresorbable Scaffolds
- Sponsor
- Rudolf Berger
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- adverse post-stenting results
- Last Updated
- 12 years ago
Overview
Brief Summary
The biodegradable ABSORB scaffold is characterized by a greater strut thickness, but it has a greater flexibility compared to the XIENCE stent. Due to its fragility the inflating pressure of the ABSORB scaffold is limited and suitable lesions have to be well prepared. This study assesses the incidence of malapposed stent-struts, and the frequency of stent-underexpansion and edge dissection after ABSORB implantation compared to the XIENCE stent.
Investigators
Rudolf Berger
Associate Professor
Medical University of Vienna
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
adverse post-stenting results
Time Frame: 1 year
Malapposition, underexpansion and edge dissections assessed with Optical Coherence Tomography (OCT)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Obseravtional study evaluating the perfomance of the bioabsorbable stent (scaffold) in every day clinical practicePatients presenting with NSTEMI stable or unstable angina, or silentNL-OMON27706Investigator Initiated study (Erasmus MC)300
Completed
Not Applicable
Independent OCT Registry on Very Late Bioresorbable Scaffold ThrombosisCoronary ThrombosisTomography, Optical CoherenceDrug-Eluting StentsNCT03180931Insel Gruppe AG, University Hospital Bern36
Active, not recruiting
Phase 4
Bioresorbable vascular scaffolds in ST-elevation myocardial infarction – OCT-guided implantation and mid-term OCT resultsdI21Acute myocardial infarctionDRKS00009788niversitätsklinikum Bonn26
Terminated
Phase 4
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery DiseasePercutaneous Transluminal Coronary AngioplastyNCT02831205Duk-Woo Park, MD800
Terminated
Not Applicable
Plaque Stabilization and Restoration by Bioresorbable Vascular ScaffoldVulnerable PlaqueNCT02319733Canisius-Wilhelmina Hospital1